Sfoglia per Autore
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
2007 Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpiaz G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M.
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
2010 Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M.
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.
2010 Zinzani PL; Venturini F; Stefoni V; Fina M; Pellegrini C; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M.
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients.
2010 Zinzani P.L.; Rossi G.; Franceschetti S.; Botto B.; Di Rocco A.; Cabras M.G.; Petti M.C.; Stefoni V.; Broccoli A.; Fanti S.; Pellegrini C.; Montini G.C.; Gandolfi L.; Derenzini E.; Argnani L.; Fina M.; Tucci A.; Bottelli C.; Pileri S.; Baccarani M.
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
2011 Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M.
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified.
2011 Zinzani P.L.; Pellegrini C.; Broccoli A.; Stefoni V.; Gandolfi L.; Quirini F.; Argnani L.; Berti E.; Derenzini E.; Pileri S.; Baccarani M.
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
2011 Zinzani PL; Gandolfi L; Broccoli A; Argnani L; Fanti S; Pellegrini C; Stefoni V; Derenzini E; Quirini F; Baccarani M.
Mycosis fungoides: disease evolution of the "lion queen" revisited.
2012 Quaglino P;Pimpinelli N;Berti E;Calzavara-Pinton P;Lombardo GA;Rupoli S;Alaibac M;Arcaini L;Bagnato S;Baldo A;Bottoni U;Carbone A;Cestari R Clerico R;De Renzo A;Fava P;Fierro MT;Filotico R;Fimiani M;Frontani M Girgenti V;Goteri G;Leali C;Mamusa AM;Mariotti G;Mastrandrea V;Pellegrini C;Pennese E;Pileri A;Savoia P;Stelitano C;Titli S;Virgili A;Zichichi L;Zinzani PL;Bernengo MG
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).
2012 Zinzani PL; Derenzini E; Pellegrini C; Rigacci L; Fabbri A; Gandolfi L; Argnani L; Casadei B; Pulsoni A; Gobbi M; Perotti A; Zaccaria A; Voso MT; Cabras MG; De Renzo A.
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
2012 Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M.
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients.
2012 Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati M; Bandini G.
Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.
2013 Zinzani PL;Pellegrini C;Derenzini E;Argnani L;Pileri S
Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports.
2013 Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL
Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.
2013 Zinzani PL;Pellegrini C;Broccoli A;Casadei B;Argnani L;Pileri S
Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series.
2013 Derenzini E;Casadei B;Pellegrini C;Argnani L;Pileri S;Zinzani PL
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study
2013 Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M.
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
2013 Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.
2013 Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials.
2013 Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gianni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L
Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin.
2013 Pastorelli F;Derenzini E;Plasmati R;Pellegrini C;Broccoli A;Casadei B;Argnani L;Salvi F;Pileri S;Zinzani PL
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. | Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpia...z G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Hairy cell leukemia: evaluation of the long-term outcome in 121 patients. | Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; P...ileri S; Baccarani M. | 2010-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. |
Zinzani PL; Venturini F; Stefoni V; Fina M; Pellegrini C; Derenzini E; Gandolfi L; Broccoli A; A...rgnani L; Quirini F; Pileri S; Baccarani M. |
2010-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients. | Zinzani P.L.; Rossi G.; Franceschetti S.; Botto B.; Di Rocco A.; Cabras M.G.; Petti M.C.; Stefoni... V.; Broccoli A.; Fanti S.; Pellegrini C.; Montini G.C.; Gandolfi L.; Derenzini E.; Argnani L.; Fina M.; Tucci A.; Bottelli C.; Pileri S.; Baccarani M. | 2010-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. | Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argn...ani L.; Pileri S.; Baccarani M. | 2011-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. | Zinzani P.L.; Pellegrini C.; Broccoli A.; Stefoni V.; Gandolfi L.; Quirini F.; Argnani L.; Berti ...E.; Derenzini E.; Pileri S.; Baccarani M. | 2011-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. | Zinzani PL; Gandolfi L; Broccoli A; Argnani L; Fanti S; Pellegrini C; Stefoni V; Derenzini E; Qui...rini F; Baccarani M. | 2011-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Mycosis fungoides: disease evolution of the "lion queen" revisited. | Quaglino P;Pimpinelli N;Berti E;Calzavara-Pinton P;Lombardo GA;Rupoli S;Alaibac M;Arcaini L;Bagna...to S;Baldo A;Bottoni U;Carbone A;Cestari R Clerico R;De Renzo A;Fava P;Fierro MT;Filotico R;Fimiani M;Frontani M Girgenti V;Goteri G;Leali C;Mamusa AM;Mariotti G;Mastrandrea V;Pellegrini C;Pennese E;Pileri A;Savoia P;Stelitano C;Titli S;Virgili A;Zichichi L;Zinzani PL;Bernengo MG | 2012-01-01 | GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA | - | 1.01 Articolo in rivista | - |
| Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). |
Zinzani PL; Derenzini E; Pellegrini C; Rigacci L; Fabbri A; Gandolfi L; Argnani L; Casadei B; Pul...soni A; Gobbi M; Perotti A; Zaccaria A; Voso MT; Cabras MG; De Renzo A. |
2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. | Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati... M; Bandini G. | 2012-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients. | Zinzani PL;Pellegrini C;Derenzini E;Argnani L;Pileri S | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports. | Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL | 2013-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients. | Zinzani PL;Pellegrini C;Broccoli A;Casadei B;Argnani L;Pileri S | 2013-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series. | Derenzini E;Casadei B;Pellegrini C;Argnani L;Pileri S;Zinzani PL | 2013-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study | Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Pucc...ini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. | Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L | 2013-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. | Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gia...nni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L | 2013-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | haematol.2012.083048.full.pdf |
| Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. | Pastorelli F;Derenzini E;Plasmati R;Pellegrini C;Broccoli A;Casadei B;Argnani L;Salvi F;Pileri S;...Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile